Cara Therapeutics Inc
NASDAQ:TVRD

Watchlist Manager
Cara Therapeutics Inc Logo
Cara Therapeutics Inc
NASDAQ:TVRD
Watchlist
Price: 4.23 USD -2.31% Market Closed
Market Cap: 39.7m USD

Intrinsic Value

The intrinsic value of one TVRD stock under the Base Case scenario is 3.31 USD. Compared to the current market price of 4.23 USD, Cara Therapeutics Inc is Overvalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TVRD Intrinsic Value
3.31 USD
Overvaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cara Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about TVRD?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TVRD valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cara Therapeutics Inc.

Explain Valuation
Compare TVRD to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CARA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cara Therapeutics Inc

Current Assets 43.8m
Cash & Short-Term Investments 37.9m
Receivables 4.5m
Other Current Assets 1.4m
Current Liabilities 4m
Accounts Payable 1.4m
Accrued Liabilities 2.5m
Non-Current Liabilities 44.4m
Other Non-Current Liabilities 44.4m
Efficiency

Free Cash Flow Analysis
Cara Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cara Therapeutics Inc

Revenue
7.1m USD
Cost of Revenue
-620k USD
Gross Profit
6.5m USD
Operating Expenses
-59.3m USD
Operating Income
-52.8m USD
Other Expenses
-18m USD
Net Income
-70.9m USD
Fundamental Scores

TVRD Profitability Score
Profitability Due Diligence

Cara Therapeutics Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Gross Margin is Increasing
Declining Net Margin
16/100
Profitability
Score

Cara Therapeutics Inc's profitability score is 16/100. The higher the profitability score, the more profitable the company is.

TVRD Solvency Score
Solvency Due Diligence

Cara Therapeutics Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
53/100
Solvency
Score

Cara Therapeutics Inc's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TVRD Price Targets Summary
Cara Therapeutics Inc

Wall Street analysts forecast TVRD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TVRD is 15.15 USD with a low forecast of 4.04 USD and a high forecast of 54.6 USD.

Lowest
Price Target
4.04 USD
4% Downside
Average
Price Target
15.15 USD
258% Upside
Highest
Price Target
54.6 USD
1 191% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cara Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CARA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CARA Insider Trading
Buy and sell transactions by insiders

TVRD News

Other Videos
What is the Intrinsic Value of one TVRD stock?

The intrinsic value of one TVRD stock under the Base Case scenario is 3.31 USD.

Is TVRD stock undervalued or overvalued?

Compared to the current market price of 4.23 USD, Cara Therapeutics Inc is Overvalued by 22%.

Back to Top